Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2006-08-22
Product name
Stop solution; part of "TNFalpha, Human, Biotrak
CAS No.
7664-38-2
supplier name
GE Healthcare UK Ltd
Icons in SDS
Company Information
company name
GE Healthcare UK Ltd
GHS Information
Signal word
DANGER!
Section 2
SECTION 2: Hazards identification
This material is considered hazardous by the OSHA Hazard Communication Standard ( 29 CFR 1910. 1200 ) Physical state Liquid. Odor Odorless. OSHA/HCS status This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Emergency overview DANGER! CAUSES RESPIRATORY TRACT, EYE AND SKIN BURNS. MAY BE HARMFUL IF SWALLOWED. CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA. Corrosive to the eyes, skin and respiratory system. Causes burns. May be harmful if swallowed. Do not breathe vapor or mist. Do not ingest. Do not get in eyes or on skin or clothing. Contains material that may cause target organ damage, based on animal data. Use only with adequate ventilation. Keep container tightly closed and sealed until ready for use. Wash thoroughly after handling. Routes of entry Dermal contact. Eye contact. Inhalation. Ingestion.
Potential Acute Health Effects
Eyes Corrosive to eyes. Causes burns. Skin Corrosive to the skin. Causes burns. Inhalation Corrosive to the respiratory system. Ingestion Harmful if swallowed. May cause burns to mouth, throat and stomach.
Potential chronic health
effects Contains material that may cause target organ damage, based on animal data. Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which may cause damage to the following organs: lungs, upper respiratory tract, skin, eye, lens or cornea. Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion Adverse symptoms may include the following: stomach pains Skin Adverse symptoms may include the following: pain or irritation redness blistering may occur Eyes Adverse symptoms may include the following: pain watering redness
Medical Conditions Generally Aggravated by Exposure
Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk may be over-exposure aggravated by over-exposure to this product. See toxicological information (section 11)